Question · asked by 1 review
Antidepressants vs placebo: Non‐serious adverse events Timing of outcome assessment: end of treatment
- Population
- patients with borderline personality disorder
- Intervention
- Antidepressants
- Comparison
- placebo
- Outcome
- Non‐serious adverse events Timing of outcome assessment: end of treatment
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Antidepressants vs placebo Non‐serious adverse events Timing of outcome assessment: end of treatment · people with borderline personality disorder The review found no eligible studies for this question. Pharmacological interventions for people with borderline personality disorder (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.